Abstract In this study, biocellulose (BC) membranes have been investigated as caffeine topical delivery systems, for the potential treatment of cellulite. BC-caffeine membranes were prepared by a simple approach and the permeation of caffeine through human epidermis, from BC or from conventional formulation systems (solution and gel), was compared in vitro to assess their therapeutic applicability. Diffusion studies with Franz cells showed that the incorporation of caffeine in BC membranes provided lower permeation rates than those obtained with the conventional formulations. These results combined with the possibility of producing BC membranes with different shapes demonstrate that these materials are promising biosystems for topical delivery of caffeine, showing reproducibility and an extended and predictable caffeine release over time, leading to their potential use for cellulite attenuation.
Introduction
The search for high-quality standards of life with a constant improvement of hygiene, health care and cosmetic products has been one of the driving forces of research activities over the last several decades. On this perspective, the development of advanced functional materials for dermal applications, such as in controlled drug release and cosmetics, have gained considerable attention (Wiegand and Hipler 2010) .
Although a wide number of synthetic materials have been developed for this purpose (Nair and Laurencin 2006) , there has been a growing interest on the development of materials based on natural polymers, mainly because of their natural biocompatibility and biodegradability, but also due to their renewable character and specific properties (Rinaudo 2008) . Among natural polymers, cellulose fibers have found extensive applications in the biomedical and cosmetic fields (Klemm et al. 2006; Kamel et al. 2008) . Although most available cellulose is produced by green plants, some microorganisms, like several bacteria, are also able to produce an extracellular form of cellulose, named biocellulose or bacterial cellulose (BC) (Klemm et al. 2001) . Gluconacetobacter xylinus is probably the most commonly referred producing strain (Budhiono et al. 1999; Shoda and Sugano 2005) . However, we have recently reported that Gluconacetobacter sacchari also produces BC in very high yields (Trovatti et al. 2011a) .
BC is produced in the form of a highly swollen membrane (with *99 % water) (Klemm et al. 2001) on the surface of the culture medium. This membrane shows a tridimensional micro-and nanofibrillar structure, with fibrils with 3-4 nm thick and 70-80 nm length (i.e. about hundred to thousand times thinner than typical plant cellulose fibers) (Hirai et al. 2002) . These properties impart BC with unique physical and mechanical properties such as tensile strength and extensibility values similar to those of human skin (Hu and Catchmark 2010) . Those properties, together with its inherent biocompatibility, triggered considerable interest on this material, particularly in the biomedical area, namely as scaffolds for tissue engineering (Helenius et al. 2006; Andrade et al. 2011; Yang et al. 2011; Martínez et al. 2012) , wound healing membranes, chirurgical implants, substitutes of natural skin (Czaja et al. 2006a, b; Sanchavanakit et al. 2006; Hu and Catchmark 2011) and wound dressings (Fontana et al. 1990; Mayall et al. 1990; Wiegand and Hipler 2010; Meftahi et al. 2010; Wang et al. 2011) .
In dermal applications such as wound dressing, BC is particularly promising since, in addition to promoting tissue regeneration, its nanofibrillar structure represents a barrier to microorganisms, and is responsible for a high capacity to absorb exudates (Czaja et al. 2006a (Czaja et al. , b, 2007 ; furthermore its high elasticity and conformability allows easy and painless healing of the wound (Wiegand and Hipler 2010; Wang et al. 2011) . BC can also be an excellent support for inclusion of active compounds and therefore for the development of specific systems for controlled dermal release of drugs associated with wound dressing. Indeed, composite materials of molecular imprinted polymers with BC have been used as reservoirs for the topical/transdermal release of drugs (Bodhibukkana et al. 2006) . Furthermore the use of pure BC membranes for the controlled release of lidocaine hydrochloride and ibuprofen has also been reported (Trovatti et al. 2011b (Trovatti et al. , 2012 . In addition, BC specific properties have been also explored in the cosmetic field. Currently, there are two BC based cosmetic masks in the market, namely ''BioCellulose'' and NanoMasque Ò , in which BC is impregnated with active substances commonly applied in cosmetics (Siqueira et al. 2010 ) and showed to significantly enhance skin moisture levels (Boonme et al. 2011) . Finally, BC in vivo skin compatibility for dermal applications has been recently demonstrated by a clinical study (Almeida et al. 2013) .
Following these research lines we decided to search for new potential health/cosmetic applications of BC for the controlled topical release of active substances.
Cellulite is a common localized metabolic disorder of the subcutaneous tissue, evidenced by skin dimpling. It is estimated that between 85 and 98 % of postpubertal human females display some degree of cellulite (Avram 2004) . Cellulite is caused by the herniation of the subcutaneous fat within fibrous connective tissue, leading to an orange peel like appearance, and occurs mainly in the thighs, pelvic region and abdomen areas. Despite some controversy (Siddons 2013) , several studies suggest that caffeine can break down the stored fat through stimulation of the lipolysis process, reducing fat cell deposits (Lupi et al. 2007; Velasco et al. 2008) .
Due to unwanted side effects of ingestion of caffeine, like nervous excitation, sleep disturbances, heart rate increase and diuresis (Pires-de-Campos et al. 2008) , its application in cellulite treatment is preferably topical. Although semi-solid topical formulations show positive results in the attenuation of cellulite they display several drawbacks such as lack of reproducibility of applied drug dose as well as losses due to absorption of the gel by contact with clothing or other surfaces. Recently, some innovative products where caffeine is incorporated in specific textiles, aiming at a continuous/controlled release throughout the day were introduced in the market (Garnier Bodytonic 2013) .
In this context, the aim of the present study was to evaluate the potential of BC membranes for topical caffeine delivery. BC membranes were loaded with a specific amount of caffeine and characterized in terms of morphology and drug release profiles into buffer solutions. Finally, in vitro diffusion studies were carried out using human epidermal membranes and Franz cells and the permeation of caffeine from BC was compared with aqueous and gel formulations.
Materials and methods

Chemicals and materials
Caffeine ([99 %, water solubility: 16 mg ml -1 ) and glycerol (99.5 %) were purchased from SigmaAldrich. All other reagents were of analytical grade (Sigma-Aldrich). Carbopol 940 (98 %), a poly(acrylic acid) based commercial formulation, was supplied by J.M. Vaz Pereira Lda, Lisbon.
Preparation of BC membranes BC membranes (99 % water content) were produced in our laboratory using conventional Hestrin-Schramm culture media (Hestrin and Schramm 1954) and G. sacchari bacteria as described elsewhere (Trovatti et al. 2011a) . After growing for 4-6 days, BC membranes were removed from culture media, washed three times with 0.5 M NaOH at 80°C for 30 min, then thoroughly washed with tap water up to neutral pH and with distilled water to remove all impurities. Pure BC membranes were kept in distilled water in a sterile environment at 4°C until their use (Trovatti et al. 2011a, b) .
Preparation of BC-caffeine (BC-caf) membranes
Wet BC membranes, with 7 cm diameter 9 0.8 cm thickness (around 160 mg of dry BC) were weighed and 60 % of their water content was drained by handpressing between two acrylic plates at room temperature.
BC membranes were then soaked in 8 ml of a solution containing caffeine (3.85 % w/v), glycerol (1 % w/v) and ethanol (5 % w/v) in aqueous potassium phosphate buffered saline solution (PBS) with pH adjusted to 5 to approach skin pH. After the complete absorption of the solution, the BC-caf membranes were placed over Petri dishes and dried at 40°C in a ventilated oven for 16 h. The dried BCcaf membranes were kept in a desiccator until their use. The final caffeine content of the BC membranes was 8 mg cm -2 . FTIR-ATR spectra of BC and BC-caf dried membranes (as well as of the individual components) were obtained on a Perkin Elmer spectrometer equipped with a single horizontal Golden Gate ATR cell. Thirtytwo scans were acquired in the 4,000-600 cm -1 range, with a resolution of 4 cm -1 .
BC and BC-caf samples for scanning electron microscopy (SEM) analysis were obtained by cutting an adequate size of membrane, while for cross-section images the membranes were broken after emerging them in liquid nitrogen in order to obtain a clear image of the cross-section. The samples were then covered with carbon and submitted to SEM, in a Hitachi SU-70 microscope at 4 and 10 kV.
Preparation of caffeine gel and solution formulations
A 2 % caffeine solution (w/v) was prepared using a PBS solution adjusted to pH 5 to approach skin pH.
A gel with 2 % of caffeine (w/v) was prepared by dissolving 2 g of caffeine in 90 ml of distilled water followed by the addition of 500 mg of Carbopol 940 and sonication of the mixture for 20 min. After complete dissolution, the volume was adjusted to 100 ml by addition of *10 ml of an aqueous NaOH solution (2 % w/v) to neutralize carbopol acidic groups and to adjust the final pH to 5.
Quantitative analysis of caffeine
Caffeine quantification in the solutions resulting from the dissolution and permeation assays, was carried by UV spectrophotometry at 273 nm on a Thermo Scientific Evolution 600 spectrophotometer, using the following linear calibration curve: Abs 273nm = 0.0328 [caf] ? 0.0129; R 2 = 0.9999, in the range of 2.5-25 lg ml -1 of caffeine. At this wavelength, glycerol does not present any absorption and no variations on the absorption maximum wavelength nor in the extinction coefficient of caffeine were perceived for different pHs.
BC-caf membranes swelling ratio
Dried BC and BC-caf membranes were weighed and then soaked in individual containers with distilled water at room temperature until constant weight, during 16 h. Samples were taken out of the water, the excess of water was gently removed with absorbent paper and membranes were weighed and reimmersed again. The swelling of membranes was calculated as: [(w wet -w dry )/w dry ] 9 100 %, where w dry and w wet are the weights of dried and wet samples. Cellulose (2014) 21:665-674 667 In vitro caffeine release into a buffer solution (dissolution assays)
BC-caf dried membranes were placed in an Erlenmeyer containing 500 ml of PBS solution at pH 7.4 to approach blood pH. Caffeine release was then carried out at 32°C and under magnetic stirring. At determined time intervals, 3 ml of solution were withdrawn, and the same volume of fresh buffer was added to maintain a constant volume. The caffeine content in each aliquot was determined by UV spectrophotometry as described above. The caffeine content at each time was plotted as a cumulated percentage release (Cumulative = C n ? (3 9 C n-1 )/500; where C n-1 and C n are the caffeine concentrations at time n -1 and n). Six replicates were performed for each sample.
In vitro permeation tests
Human abdominal skin tissue from cosmetic surgery obtained following informed consent was used to produce epidermal membranes. Ethical approval was provided by the Ethics Committee of the Faculty of Health Sciences of the Lusófona University. After removal of the adipose tissue by blunt dissection, the epidermis was separated by immersing the skin in water at 60°C for 1 min (Kligman and Christophel 1963) . It was then pinned on a cork-board, the epidermis was carefully peeled away from the dermis and mounted on filter paper, after which it was stored in a freezer at -20°C until required. Prior to the diffusion experiment, the epidermis was defrosted and cut to appropriate size. Permeation experiments (n = 5) with epidermal membranes were conducted on glass Franz type diffusion cells with a receptor volume of *4 ml and a diffusional area of 0.95 cm 2 . The continuously stirred receptor medium was an isotonic PBS solution (pH = 7.4). The receptor compartment was thermostated at 37°C.
A measured dose of caffeine (Table 1) was placed in each donor compartment, using a micropipette for the solution and the gel, while for BC membranes a 0.95 cm 2 circular shape that fitted the surface area of the donor compartment was used. 100 ll of PBS solution was applied onto the BC membranes to ensure a complete contact with the epidermal surface. The diffusion experiments were performed under occluded conditions by sealing the donor compartment with microscope coverslips. At established time intervals (Fig. 5 ) the receiver solution was completely withdrawn from the receptor compartment and immediately replaced with fresh and pre-thermostated PBS solution. The caffeine content of the withdrawn solution was measured by UV spectrophotometry as described above.
Results and discussion
BC-caf preparation and characterization
Bacterial cellulose was obtained at the end of 4-6 days in the form of 6-8 mm thickness membranes and then purified, as described in the experimental section, to remove all bacteria and culture medium that might be imbedded in the membrane. Then 60 % of the water in the membranes was drained by applying pressure, in order to facilitate the absorption of the caffeine/glycerol/ ethanol buffer solution. Glycerol was used because of its plasticizing effect which increases the flexibility of the membranes (Trovatti et al. 2011b (Trovatti et al. , 2012 as well as its humectant properties (Rawlings et al. 2002; Almeida et al. 2013 ). The prepared BC-caf membranes present a caffeine content of 8 mg per cm 2 (Table 1 ). The visual aspect of BC-caf membranes, in wet and dry form is shown in Fig. 1 . The wet membranes appear as malleable swollen gels (left), while in the dried state (right) they become thin white films with some malleability due to the mentioned plasticizing effect of glycerol. The morphology of the BC and BC-caf dried membranes was assessed by surface and cross-section SEM analyses. Figure 2 shows the typical BC tridimensional nanofibrillar network. The same structure is revealed in the presence of caffeine (Fig. 2) .
These SEM images suggest also a good dispersion of caffeine in the BC membrane surface, since no formation of aggregates or crystallized caffeine is observed. Furthermore, the cross-section images (Fig. 2) illustrate the good dispersion of caffeine inside the BC membrane. In pure BC membranes fewer spaces between strands are observed because of the collapse of the nanofibrillar structure upon drying, while in the BC-caf membrane these spaces are higher certainly due to the presence of glycerol and caffeine. In fact, it is perceptible that the cellulose nanofibers are covered by a layer of caffeine and glycerol. Glycerol molecules will be incorporated into the BC network, reducing the intermolecular attraction forces, maintaining some mobility of the nanofibres and, therefore, keeping some flexibility. Another important factor is that glycerol is highly hydrophilic and will favour the penetration and imprisonment of water molecules between the cellulose nanofibers. As caffeine was solubilised in the presence of glycerol, it also benefited the absorption and dispersion of the solution throughout the BC membrane (Fig. 2) .
The FTIR spectrum of the BC membrane (Fig. 3A) shows typical peaks of a cellulosic substrate. The band at around 3,300 cm -1 corresponds to the vibration of the OH groups and the peaks between 2,900 and 2,800 cm -1 are associated with the axial deformation of CH and CH 2 groups (CHOH and CH 2 OH). The peaks with lower wavelength values, around 1,300-1,400 cm -1 correspond to the angular bending of C-OH and CH groups, the peaks at 1,150-900 cm -1 , are associated with the C-H bonds of CH 2 groups and the stretching of C-O-C groups. The spectrum of glycerol (Fig. 3A) presented also a broad absorption band at 3,300 cm -1 associated with the vibrations of the OH groups and at around 2,900 cm -1 are the peaks of the vibrational frequencies of C-H groups. The C-O absorptions characteristic of secondary and primary alcohols occurs at 1,090 and 1,035 cm -1 , respectively. The FTIR spectrum of pure caffeine (Fig. 3A) showed characteristic peaks of the vibrations of the C-H (3,000-2,850 cm -1 ) methyl groups. The spectrum region from 1,700 to 1,400 cm -1 comprehends the C=N, C=O, and C=C bond vibrations and between 1,300 and 1,000 cm region are the C-N, C-C bond vibrations. The BC-caf FTIR spectrum (Fig. 3A) is a sum of all individual constituents, with no appearance of new peaks or noticeable shifts in peaks position, indicating the absence of complex interactions. In addition, FTIR spectra collected at different points of the surface and cross-section regions of the BC-caf membranes (Fig. 3B, C) showed very similar profiles, confirming 
Swelling assays
The swelling behaviour of BC-caf membranes is an important parameter since this process is a determining step in the re-hydration in contact with skin, as well as, in the rate of release of caffeine. The maximum swelling ratio of dried BC, and BC-caf membranes prepared in the conditions described were 133 ± 1.5 and 284 ± 5.7 % respectively, reached at the end of 2 h. However, after 5 min, 85 % swelling was already observed, which is in agreement with previously published results (Trovatti et al. 2011b ). The higher swelling ratio of BC-caf membrane is due to the humectant and highly hydrophilic properties of glycerol which are known to have a considerable impact in the swelling ability of the BC membrane (Trovatti et al. 2011b) . BC-caf swelling value is lower than that observed for BC membranes with the same amount of glycerol but containing no caffeine (*430 %, results not shown). This is most likely due to the lower solubility of caffeine in water comparatively with glycerol; the observed swelling increment will play a key role in the release of caffeine from the membranes, upon contact with skin.
In vitro dissolution assays
The profile of caffeine release from BC-caf immersed in PBS buffer solutions at 32°C shows that around 80 % of the drug present in the membranes was released in the first 5 min (Fig. 4) . Caffeine release is obviously dependent on BC-caf swelling, which as discussed above reached 85 % at the end of the same period. Considering the solubility of caffeine in water (16 mg ml -1 at room temperature) and the large buffer solution volumes used in this assay, the release of caffeine from the BC membranes is essentially governed by diffusion throughout the polymeric porous and tridimensional matrix, being favoured by the high swellability of the BC-caf membranes, previously demonstrated. The higher hydrophobicity of caffeine when compared to previously studied drugs (Trovatti et al. 2011b (Trovatti et al. , 2012 , also contributes to its fast release because of the poor interactions established with the BC nanofibrils, as suggested by the FTIR analysis. Finally, around 20 % of caffeine was not released during the time frame (15 min) of the test; although apparently a plateau was reached, it is expected that for longer release periods caffeine dissolution should be completed.
In vitro permeation assays
The permeation profiles of caffeine from the different systems through epidermal membranes are shown in Fig. 5 . Depending on the formulation system (Table 1) , different steady-state flux values (Js) were obtained, as seen in Table 2 . The highest caffeine fluxes were obtained in the aqueous solution (7.53 lg cm -2 h -1 ) and the lowest in the BC-caf membrane (2.55 lg cm -2 h -1 ). Furthermore, although the flux for BC-caf is around 58 % of the flux of the gel, it will allow a longer release and higher skin accumulation because of the loss of material due to contact with garments or surfaces that will occur for the gel and the solution, as opposed to the BC-caf system that will persist on the skin for a longer time.
A comparison of the different formulations based on the cumulative amount permeated after 10 h, as well as the permeability coefficient Kp, provides the same trends observed in the fluxes ( Table 2) , showing that the highest percentage of caffeine permeated was obtained for the aqueous solution, while the lowest was observed for BC-caf (0.97 and 0.39 % respectively).
Different caffeine concentrations were used in the BC-caf system and in the gel, which could partly explain the differences in the fluxes. Nevertheless, some authors have found poor correlations between drug concentration and flux (Akhter and Barry 1985) and numerous topical formulations have shown clinical equivalence despite containing different concentrations of the same drug (Peltonen and Solberg 1984) .
On the other hand, equivalent doses of caffeine were employed in the permeation studies for every formulation. It is, therefore, reasonable to assume that in the present work the factors that are involved in the lower fluxes obtained from BC membranes can be attributed to differences in the resistance opposed by the formulation to the diffusion of the drug, which will appreciably influence the drug release. Specifically, the complex tridimensional organization of BC membranes makes the diffusion pathway of the drug tortuous and slows the drug release rate, particularly in comparison with the aqueous solution. Furthermore, in the case of the gel formulation, the effect of viscosity on drug release is well established, and most authors have found inverse relationships between the viscosity of preparations and matrices and drug diffusion coefficients (Diezsales et al. 1991; A-sasutjarit et al. 2005 ).
Finally, in vivo studies with human volunteers will be required to determine the therapeutic efficacy of the dose released by a BC-caf system.
Conclusions
Homogeneous caffeine-loaded BC membranes were prepared through a very simple approach. These membranes are quite flexible and presented a doubled swelling capacity when compared with the pure BC membranes, due to the incorporation of glycerol as a plasticizer. The permeation rate of BC-caf membranes was significantly lower than those obtained on aqueous and gel formulations, leading us to conclude that BC membranes are promising biomaterials for topical delivery of caffeine, for potential use in the attenuation of cellulite, namely by incorporation in textiles, or by designing wearable forms entirely based on BC. Mean values ± SD, n = 5
